Jade Biosciences, Inc. (JBIO) Financials

JBIO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 472.1 million 32.2 million
March 31, 2026 319.4 million 23.0 million
Dec. 31, 2025 349.8 million 17.3 million
Sept. 30, 2025 202.5 million 23.1 million

JBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -43.7 million ?
March 31, 2026 -24.1 million 7.4 million
Dec. 31, 2025 -33.7 million 9.4 million
Sept. 30, 2025 -22.2 million 4.3 million

JBIO Net Income

No data available :(

JBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 461.2 million - 628000
March 31, 2026 311.3 million - 679000
Dec. 31, 2025 336.2 million - 724000
Sept. 30, 2025 198.9 million - 747000

JBIO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 61.1 million
March 31, 2026 57.8 million
Dec. 31, 2025 49.3 million
Sept. 30, 2025 39.6 million

JBIO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 50.1 million 8.8 million -
March 31, 2026 - 36.1 million 7.4 million -
Dec. 31, 2025 3000 28.5 million 6.4 million 100000
Sept. 30, 2025 57000 22.0 million 5.4 million -

JBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 9000
March 31, 2026 - 9000
Dec. 31, 2025 - 9000
Sept. 30, 2025 - 12000

JBIO

Price: $21.23

52 week price:
6.67
28.00

Earnings Per Share: -1.02 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.5 billion

Links: